Dr James Roberts has a background in cellular and molecular physiology, acquiring a PhD at the University of Liverpool in 2024 exploring how the cytoprotective transcription factor NRF2 can mitigate the cardiotoxicity induced by chemotherapeutics. In his role as a post-doctoral research fellow, Dr Roberts investigates novel therapeutics and drug delivery strategies for neurodegenerative diseases such as age-related macular degeneration and glaucoma in a variety of preclinical models. This research supports the neuroscience and ophthalmology team led by Professor Lisa Hill and Dr Hannah Botfield.
Dr Roberts is also integrated within a portfolio of traumatic brain injury (TBI) clinical studies including mTBI-Predict, a major international project funded by The U.S. Department of Defense, specifically within the biofluids workstream.
Dr Roberts is passionate about translating research into tangible impact for patients through a variety of pathways including collaboration and commercialisation. Moreover, he is dedicated to advancing the next generation of researchers by providing supervision (including BSc and MSci projects), laboratory training and comprehensive support for their personal and professional development.